Awards and Achievements

USFDA Approved Manufacturing Facility since 1998

Morepen also holds process patents for Montelukast Sodium Amorphous in Global, USA, Canada, Europe & India.

Awards and Achievements

ISO Certified medical devices Manufacturing Facility

ISO 9001:2005 and ISO 13485:2016 certification for medical devices manufacturing facility at Baddi (H.P.). This enables us as one of the largest manufacturers in point-of-care diagnostic devices in India.

Awards and Achievements

Awarded 3 years consecutively by Pharmexcil

Awarded Certificate of Appreciation by Pharmaceuticals export promotion council (Pharmexcil), setup by Ministry of Commerce & Industry, Government of India for 3 consecutive years.

Investor Centre

Q4 FY24 Revenue: Gross revenue of INR 427 crores, 16.5% increase from INR. 367 crores in Q4’FY23.

EBITDA for Q4’FY24 surged by 182% to INR 52.62 crores from INR. 18.68 crores in the same quarter last year. For the full fiscal year, EBITDA more than doubled, achieving INR. 172.60 crores, up 101% from INR. 85.67 crores in FY23

Annual FY24 Revenue: INR 1704 crores, a notable 20% rise compared to INR 1424 crores in FY23.

PBT for Q4’FY24 was INR. 42.20 crores, a substantial increase of 279% from INR. 11.14 crores in Q4 FY23. Annually, PBT grew by 143% to INR. 135.42 crores from INR. 55.76 crores in FY23.

PAT for Q4’FY24 stood at INR. 28.74 crores, showing a 249% growth compared to INR. 8.24 crores in the same period last year. On an annual basis, PAT increased by 150% to INR. 96.62 crores from INR. 38.68 crores in FY23.

Earnings Per Share (EPS): Jumped from INR 0.77 to INR 1.88 for FY24, indicating a great start to the journey ahead.

Q3'FY24 Revenue at Rs. 449 crores is up by 28% on a y-o-y basis. 9M revenue of Rs. 1277 crores, is up 21%.

Domestic revenue for the Q3 at Rs. 271 crores is up by 27%. For the 9M period, at Rs. 829 Crores, revenue growth is at 30%

API total revenue at Rs. 253 Crores for Q3 is up by 20% on a y-o-y basis, whereas for a 9M period at Rs. 668 Crores

Revenues growth is at 10%. API Q3 exports at Rs. 176 Crores are up by 31% while Domestic Business is up only 1%.

Q3 revenue for the Formulation business at Rs. 65 crores is up by 40% whereas, for 9 months period, revenue growth is at 22% for Rs. 166 Crores

The medical devices business continues its high growth journey with 24% revenue growth in Q3 and a 37% jump in the 9M period.

Self-monitor health with Dr.Morepen

"Dr. Morepen’s devices are user-friendly, quick and reliable. With the help of these devices, we may in fact add Health to our DIY lists, instead of depending on others!”

Dr. Morepen’s clear and accurate result

"Dr. Morepen's device provides a clear and accurate result. Keep an instant check on your bp with the help of BP monitor by Dr. Morepen.”

The original burns cream that India trusts.

Burnol a name every household trusts for quick healing of burns and cuts for more than two decades. An effective antiseptic and antibacterial topical ointment.

Quick relief from cold, cough, & flu

Lemolate Gold is a trusted medicine for cold, cough, and flu that provides superior relief without leaving you drowsy.

Sanitizer that protects!

An alcohol-based sanitizer that thoroughly disinfects your hands while keeping them soft and leaves your hands smelling great!

Awards and Achievements

USFDA Approved Manufacturing Facility since 1998

Awards and Achievements

ISO Certified medical devices Manufacturing Facility

Awards and Achievements

Awarded 3 years consecutively by Pharmexcil

Investor Centre

Self-monitor health with Dr.Morepen

Dr. Morepen’s clear and accurate result

The original burns cream that India trusts.

Quick relief from cold, cough, & flu

Sanitizer that protects!

Recent News

Morepen 40 Years Celebration #NewYearJoy #40YearsOfExcellence

Life@Morepen

BE A PART OF A CULTURE OF JOY AND PERFECTION